Patient Factors Impacting Adherence to Oral Chemotherapy

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Breast Cancer; Gastrointestinal Cancer

Treatments: Behavioral: questionnaire and interview

Study type: Observational

Funder types: Other

Identifiers

NCT01487343

11-194

Details and patient eligibility

About

The purpose of this study is to identify what makes it easier and what makes it harder to take oral chemotherapy.

Enrollment: 79 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of primary breast cancer or gastrointestinal cancer
• Currently prescribed capecitabine
• Age 21 years or older
• Able to understand written and oral English

Exclusion criteria

• Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.

Trial design

79 participants in 1 patient group

breast or gastrointestinal cancer pts taking capecitabine

Description:

This is a mixed-methodology pilot study of patients currently taking oral chemotherapy for breast or gastrointestinal cancer. The quantitative portion of the study consists of self-report questionnaires assessing adherence, beliefs about medications, side effect experience, self-efficacy, and satisfaction with patient education; the qualitative portion is an interview guided by two open-ended questions.

Treatment:

Behavioral: questionnaire and interview